EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Malignant melanoma in a 12‐year‐old boy 17 months after completing hepatoblastoma treatment

Koji Kanezawa, Hiroshi Yagasaki iD, Ayumu Arakawa, Reina Hoshi, Shuichiro Uehara iD, Ichiro Morioka

Cancer Reports · 2024

DOI: 10.1002/cnr2.2118 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cancer Reports, 2024. Verfasst von Koji Kanezawa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pediatrics, Nihon University Itabashi Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Hepatoblastoma, Melanoma, Liver Neoplasms. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Melanoma is rare as a secondary malignant neoplasm among childhood cancer survivors. Case We report a case of a 12‐year‐old boy who developed malignant melanoma with systemic metastases 17 months after completing treatment for hepatoblastoma. The diagnosis was made unexpectedly based on a bone marrow examination. The patient did not respond to immune checkpoint inhibitor therapy and died 6 weeks after being diagnosed with melanoma. Whole‐exome sequencing to examine 103 genes associated with cancer predisposition did not identify any germ‐line variants.

Conclusion

This case study provides a unique example of melanoma in a childhood cancer survivor following hepatoblastoma treatment but does not identify any candidate variant to link hepatoblastoma and melanoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepatoblastomaMelanomaLiver NeoplasmsHumansMaleChildFatal OutcomeNeoplasms, Second PrimaryExome SequencingCancer Survivors

Stichwörter der Autor:innen

chemotherapyhepatoblastomamelanomasecondary malignant neoplasm

Autor:innen und Institutionen

  • Pediatrics, Nihon University Itabashi Hospital, Tokyo, Japan.
  • Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Pediatric Surgery, Nihon University Itabashi Hospital, Tokyo, Japan.

ORCID-Profile: Hiroshi Yagasaki, Shuichiro Uehara

Zitieren

APA

Kanezawa, K., Yagasaki, H., Arakawa, A., Hoshi, R., Uehara, S., & Morioka, I. (2024). Malignant melanoma in a 12‐year‐old boy 17 months after completing hepatoblastoma treatment. Cancer Reports. https://doi.org/10.1002/cnr2.2118

Vancouver

Kanezawa K, Yagasaki H, Arakawa A, Hoshi R, Uehara S, Morioka I. Malignant melanoma in a 12‐year‐old boy 17 months after completing hepatoblastoma treatment. Cancer Reports. 2024. doi:10.1002/cnr2.2118

BibTeX
@article{Kanezawa2024,
  author = {Kanezawa, Koji and Yagasaki, Hiroshi and Arakawa, Ayumu and Hoshi, Reina and Uehara, Shuichiro and Morioka, Ichiro},
  title = {Malignant melanoma in a 12‐year‐old boy 17 months after completing hepatoblastoma treatment},
  journal = {Cancer Reports},
  year = {2024},
  doi = {10.1002/cnr2.2118}
}
Kostenlos starten →